Latest papers

Formation and properties of in vitro biofilms of ica-negative Staphylococcus epidermidis clinical isolates.

Internally quenched peptides for the study of lysostaphin: An antimicrobial protease that kills Staphylococcus aureus.

Expression of lysostaphin in HeLa cells protects from host cell killing by intracellular Staphylococcus aureus.

Staphylococcus aureus mutants with increased lysostaphin resistance.

Real-time quantitative broad-range PCR assay for detection of the 16S rRNA gene followed by sequencing for species identification.

Peptidoglycan hydrolase fusions maintain their parental specificities.

Cross-linked peptidoglycan mediates lysostaphin binding to the cell wall envelope of Staphylococcus aureus.

The effectiveness of lysostaphin therapy for experimental coagulase-negative Staphylococcus endophthalmitis.

Cytoplasmic expression of mature glycylglycine endopeptidase lysostaphin with an amino terminal hexa-histidine in a soluble and catalytically active form in Escherichia coli.

Staphylococcus aureus biofilm as a target for single or repeated doses of oxacillin, vancomycin, linezolid and/or lysostaphin.

Turnover of cell surface-bound capsular polysaccharide in Staphylococcus aureus

Reduced expression of the atl autolysin gene and susceptibility to autolysis in clinical heterogeneous glycopeptide-intermediate Staphylococcus aureus (hGISA) and GISA strains.

Engineering disease resistant cattle.

Comparison of four methods for determining lysostaphin susceptibility of various strains of Staphylococcus aureus.

New effective sources of the Staphylococcus simulans lysostaphin.

Tackling mastitis in dairy cows.

Genetically enhanced cows resist intramammary Staphylococcus aureus infection.

Cytoplasmic control of premature activation of a secreted protease zymogen: deletion of staphostatin B (SspC) in Staphylococcus aureus 8325-4 yields a profound pleiotropic phenotype.

Extended nasal residence time of lysostaphin and an anti-staphylococcal monoclonal antibody by delivery in semisolid or polymeric carriers.

Cell wall composition and decreased autolytic activity and lysostaphin susceptibility of glycopeptide-intermediate Staphylococcus aureus.